Early Drug Development: Strategy and Solution
Summary: This webinar focuses on the key considerations for transitioning small molecules from preclinical through clinical development. Topics include recent advances in vivo and ex vivo models used in preclinical studies of drug development.
In addition, experts discuss the technological aspects of drug development and describe practical approaches to improve bioavailability of poorly soluble drugs, as well as the ways physiologically based pharmacokinetic (PBPK) models are used to predict the pharmacokinetics (PK) of drugs.